RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine

Detalles Bibliográficos
Autores principales: Kolbin, A, Mishinova, SA, Syraeva, GI, Polushin, YS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232774/
http://dx.doi.org/10.1016/j.jval.2022.04.1615
_version_ 1784735669429469184
author Kolbin, A
Mishinova, SA
Syraeva, GI
Polushin, YS
author_facet Kolbin, A
Mishinova, SA
Syraeva, GI
Polushin, YS
author_sort Kolbin, A
collection PubMed
description
format Online
Article
Text
id pubmed-9232774
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92327742022-06-27 RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine Kolbin, A Mishinova, SA Syraeva, GI Polushin, YS Value Health Article Published by Elsevier Inc. 2022-07 2022-06-25 /pmc/articles/PMC9232774/ http://dx.doi.org/10.1016/j.jval.2022.04.1615 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kolbin, A
Mishinova, SA
Syraeva, GI
Polushin, YS
RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
title RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
title_full RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
title_fullStr RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
title_full_unstemmed RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
title_short RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
title_sort rwd91 a real-world pharmacovigilance study using national russian database of adverse events of covid-19-related drugs: focus on hydroxychloroquine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232774/
http://dx.doi.org/10.1016/j.jval.2022.04.1615
work_keys_str_mv AT kolbina rwd91arealworldpharmacovigilancestudyusingnationalrussiandatabaseofadverseeventsofcovid19relateddrugsfocusonhydroxychloroquine
AT mishinovasa rwd91arealworldpharmacovigilancestudyusingnationalrussiandatabaseofadverseeventsofcovid19relateddrugsfocusonhydroxychloroquine
AT syraevagi rwd91arealworldpharmacovigilancestudyusingnationalrussiandatabaseofadverseeventsofcovid19relateddrugsfocusonhydroxychloroquine
AT polushinys rwd91arealworldpharmacovigilancestudyusingnationalrussiandatabaseofadverseeventsofcovid19relateddrugsfocusonhydroxychloroquine

Ejemplares similares